EUVIMEDEUVIMED entdecken
Crossref

Single-cell and bulk transcriptomic profiling of metabolism-related lncRNAs reveals tumor heterogeneity and prognostic markers in non-small cell lung cancer

Bin Zhou, Xuelong Wang, Liwei Su, Yanchao Liu, Mengxu Zhu, Xianchao Guo, Chengwei Zhang

Clinical and Translational Oncology · 04.03.2026 · 28 (8) · 3147-3159

DOI: 10.1007/s12094-026-04293-w ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical and Translational Oncology, online erschienen am 04.03.2026. Verfasst von Bin Zhou und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thoracic Surgery, Capital Medical University Electric Power Teaching Hospital, Taipingqiao Xili No.1, Beijing, 100073, China. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, RNA, Long Noncoding, Lung Neoplasms, Biomarkers, Tumor. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 48 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: Non-small cell lung cancer (NSCLC), including lung adenocarcinoma (LUAD) and lung squamous cell carcinoma (LUSC), exhibits marked tumor heterogeneity and poor prognosis. Metabolic reprogramming is a hallmark of cancer, and long non-coding RNAs (lncRNAs) have emerged as important regulators of tumor metabolism and immune interactions. This study aimed to systematically characterize metabolism-related lncRNAs in NSCLC using single-cell and bulk transcriptomic data, and to evaluate their associations with tumor heterogeneity, immune microenvironment, and clinical outcomes. METHODS: RNA sequencing and clinical data for LUAD and LUSC were obtained from The Cancer Genome Atlas. Metabolism-related lncRNAs were identified through partial correlation analysis combined with KEGG pathway-based gene set enrichment analysis. Tumor microenvironment characteristics were assessed using CIBERSORTx. Consensus clustering based on the top 20 metabolism-related lncRNAs was applied to define molecular subtypes. Cis- and trans-regulatory relationships were explored using Spearman correlation, and competing endogenous RNA networks were constructed by integrating TargetScan-predicted miRNA-mRNA interactions. Findings were validated across six independent datasets, and single-cell transcriptomic data were used to assess cell-type-specific expression patterns. RESULTS: A subset of metabolism-related lncRNAs was significantly enriched among differentially expressed and survival-associated lncRNAs in NSCLC. AL365181.2 was identified as a key lncRNA associated with multiple metabolic pathways and poor prognosis. Single-cell analysis revealed immune cell-specific expression patterns, particularly in B cells, CD8+ T cells, and natural killer cells. Metabolic lncRNA-based clustering defined distinct molecular subtypes with significant differences in immune profiles and clinical outcomes. CONCLUSIONS: Metabolism-related lncRNAs contribute substantially to tumor heterogeneity and prognosis in NSCLC and may serve as valuable biomarkers for patient stratification and personalized therapeutic strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Non-Small-Cell LungRNA, Long NoncodingLung NeoplasmsBiomarkers, TumorHumansPrognosisGene Expression ProfilingTumor MicroenvironmentSingle-Cell Gene Expression AnalysisMetabolic ReprogrammingTranscriptomeSingle-Cell AnalysisGene Expression Regulation, NeoplasticRNA, Competitive EndogenousCarcinoma, Squamous Cell

Stichwörter der Autor:innen

Metabolic reprogrammingMetabolism-related lncRNAsNon-small cell lung cancerPrognostic biomarkerTumor microenvironment

Substanzen

RNA, Long NoncodingBiomarkers, TumorRNA, Competitive Endogenous

Autor:innen und Institutionen

  • Department of Thoracic Surgery, Capital Medical University Electric Power Teaching Hospital, Taipingqiao Xili No.1, Beijing, 100073, China.
  • Annoroad Gene Technology (Beijing) Co., Ltd, Room 701, Unit 2, Building 8, Courtyard 88, Science and Innovation Street 6, Beijing Economic and Technological Development Zone, Beijing, 100037, China.
  • Department of Thoracic Surgery, Capital Medical University Electric Power Teaching Hospital, Taipingqiao Xili No.1, Beijing, 100073, China. bjdlyyxwk@163.com.

Zitieren

APA

Zhou, B., Wang, X., Su, L., Liu, Y., Zhu, M., Guo, X., & Zhang, C. (2026). Single-cell and bulk transcriptomic profiling of metabolism-related lncRNAs reveals tumor heterogeneity and prognostic markers in non-small cell lung cancer. Clinical and Translational Oncology, 28(8), 3147-3159. https://doi.org/10.1007/s12094-026-04293-w

Vancouver

Zhou B, Wang X, Su L, Liu Y, Zhu M, Guo X, et al. Single-cell and bulk transcriptomic profiling of metabolism-related lncRNAs reveals tumor heterogeneity and prognostic markers in non-small cell lung cancer. Clinical and Translational Oncology. 2026;28(8):3147-3159. doi:10.1007/s12094-026-04293-w

BibTeX
@article{Zhou2026,
  author = {Zhou, Bin and Wang, Xuelong and Su, Liwei and Liu, Yanchao and Zhu, Mengxu and Guo, Xianchao and Zhang, Chengwei},
  title = {Single-cell and bulk transcriptomic profiling of metabolism-related lncRNAs reveals tumor heterogeneity and prognostic markers in non-small cell lung cancer},
  journal = {Clinical and Translational Oncology},
  year = {2026},
  volume = {28},
  number = {8},
  pages = {3147--3159},
  doi = {10.1007/s12094-026-04293-w}
}
Kostenlos starten →